AstraZeneca submits Brilinta for FDA approval

11/19/2009 | Reuters

AstraZeneca filed for FDA approval of Brilinta, a promising rival to blockbuster blood thinner Plavix. The application comes months after AstraZeneca reported that Brilinta outperformed Plavix in a late-stage study.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager of Payer Relations
Pharmacy Quality Solutions, Inc.
Raleigh/Durham, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Vice President of Medicare
UPMC Health Plan
Pittsburgh, PA
National Affairs Analyst
Verisk Analytics
Jersey City, NJ
Corporate Regulatory Lawyer EMEA (f/m)
W. L. Gore & Associates GmbH
Putzbrunn (near Munich)